Clinical and laboratory indicators of extent of ulcerative colitis: Serum C-reactive protein helps the most

Journal of Clinical Gastroenterology

Volumn 10, Issue 1, 1988, Pages 41-45

  Prantera, C ^a   Davoli, M ^a   Lorenzetti, R ^a   Pallone, F ^b   Marcheggiano, A ^b   Iannoni, C ^b   Mariotti, S ^c  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Acute phase reactants; C reactive protein; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN;

COLON BIOPSY; COLONOSCOPY; DIAGNOSIS; HISTOCHEMISTRY; HUMAN; MAJOR CLINICAL STUDY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; COLITIS; COLITIS, ULCERATIVE; FEMALE; HUMAN; INFLAMMATION; INTESTINAL MUCOSA; MALE; MIDDLE AGE; PROCTITIS; PROCTOCOLITIS;

EID: 0023928812     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-198802000-00010     Document Type: Article

References (24)

1. Truelove SC, Witts U. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2: 1041—8.
2. Lennard-Jones JE. The clinical outcome of ulcerative colitis depends on how much the colonic mucosa is involved. Scand J Gastroenterol 1983(Suppl)88:48-53.
3. Buckell NA, Lennard-Jones JE, Hernandez MA, Kohn J, Rickes PG, Wadsworth J. Measurements of serum proteins during the attacks of ulcerative colitis as a guide to patient management. Gut 1979;20:22-7.
4. Fagan EA, Dyck RP, Maton PN, Hodgson HJF, Chadwick VS, Petrie A, Pepys MB. Serum levels of C-reactive protein in Crohn’s disease and ulcerative colitis. Eur J Clin Invest 1982;12:351-9.
5. Descos L, Andre F, Andre C, Gillon J, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis. Digestion 1983;28: 148-52.
6. Hartong WA, Arvanitakis C, Skibba RM, Klotz AP. Treatment of toxic megacolon: a comparative review of 29 patients. Am J DigDis 1977;22:195-200.
7. Morson BC, Dawson IM. Ulcerative colitis. In: Gastrointestinal pathology, 2nd Ed. St. Louis. Missouri: Blackwell Scientific Publications, 1979.
8. Wasson JH, Sox HC, NefFRK, Goldman L. Clinical prediction rules: application and methodological standards. N Engl J Med 1985;313:793-7.
9. Halperin M, Blackwelder WC, Verter J. Estimation of the multivariate risk function: a comparison of the discriminant function, and maximum likelihood approaches. J Chronic Dis 1971;24: 125-58.
10. Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlation between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. DigDisSci 1982;27:533-7.
11. Pepys MB. C-reactive protein fifty years on. Lancet 1981;1: 653-6.
12. Kaplan MH. C-reactive protein: relation to disease and pathological significance. Ann NY Acad Sci 1982;389:419-22.
13. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (Pentaxins) and serum amyloid A protein. Adv Immunol 1983;34:141-211.
14. Andre C, Descos L, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn’s disease activity index. Gut 1981;22:571-4.
15. Pettit SH, Holbrook IB, Irving MH. Comparison of clinical scores and acute phase proteins in the assessment of acute Crohn’s disease. Br J Surg 1985;72:1013-6.
16. Andre C, Descos L, Andre F, Vignal J, Druguet M. Interet du dosage de la proteine C dans le diagnostic et la mesure de l’activite de la maladie de Crohn et de la rectocolite hemorragique. Gastroenterol Clin Biol 1979;3:789-94.
17. Prantera C, Baiocchi G, Levenstein S, Livi U, Luzi C, Fanucci A. Clinical and laboratory parameters in Crohn’s disease: relation to disease activity, morphology and extent. Ital J Gastroenterol 1981;13:24-7.
18. Prantera C, Luzi C, Olivotto P, Levenstein S, Cerro P, Fanucci A. Relationship between clinical and laboratory parameters and length of lesion in Crohn’s disease of small bowel. Dig Dis Sci 1984;29:1093-7.
19. Gomes P, Du Bolay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986;27: 92-5.
20. Saverymuttu SH, Hodgson HJF, Chadwick VS, Pepys MB. Differing acute phase responses in Crohn’s disease and ulcerative colitis. Gut 1986;27:809-13.
21. Brignola C, Lanfranchi GA, Campieri M, et al. Importance of laboratory parameters in the evaluation of Crohn’s disease activity. J Clin Gastroenterol 1986;8(3):245—8.
22. Best WR, Becktel JH, Singleton JW, Kern F. Development of a Crohn’s disease activity index. Gastroenterology 1975;70:439-44.
23. Gabrielsson N, Granqvist S, Sundelin P, Thorgeirsson T. Extent of inflammatory lesions in ulcerative colitis assessed by radiology, colonoscopy, and endoscopic biopsies. Gastrointest Radiol 1979;4:359-400.
24. Lehman GA, Buchner DM, Lappas JC. Anatomical extent of fiberoptic sigmoidoscopy. Gastroenterology 1983;84:803-8.